Guerbet lands expanded FDA clearance for Dotarem

French contrast developer Guerbet said the U.S. Food and Drug Administration...Read more on AuntMinnie.comRelated Reading: EMA confirms clampdown on linear gadolinium agents Guerbet phases out 2 contrast agents Guerbet invests in French medical technology fund FDA finds no health effects from gadolinium retention Guerbet sees 7% growth in Q1 revenue
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news